BioCryst Pharmaceuticals Ownership 2024 | Who Owns BioCryst Pharmaceuticals Now?


OverviewForecastRevenueFinancialsChartTranscripts

Institutional Ownership

84.53%

Insider Ownership

1.15%

Retail Ownership

14.32%

Institutional Holders

244.00

BioCryst Pharmaceuticals Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BLACKROCK INC.9.68%0.00%19,956,2551,515,5268.22%123,329,655Jun 30, 2024
VANGUARD GROUP INC9.11%0.00%18,769,4931,092,7266.18%115,995,467Jun 30, 2024
AVORO CAPITAL ADVISORS LLC6.10%1.03%12,570,000-480,000-3.68%77,682,600Jun 30, 2024
STATE STREET CORP4.54%0.00%9,346,799-8,130,545-46.52%57,763,218,000Jun 30, 2024
KYNAM CAPITAL MANAGEMENT, LP4.28%4.21%8,826,7102,299,21935.22%54,549,068Jun 30, 2024
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)3.95%0.84%8,135,8043,140,80462.88%50,279,269Jun 30, 2024
ALKEON CAPITAL MANAGEMENT LLC3.45%0.07%7,099,4843,000,00073.18%43,874,811Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC2.29%0.00%4,710,277310,0067.05%29,115,550Jun 30, 2024
CALIGAN PARTNERS LP2.23%6.64%4,598,7373,840,235506.29%28,420,195Jun 30, 2024
NUVEEN ASSET MANAGEMENT, LLC2.18%0.01%4,495,3851,875,52471.59%27,781,480Jun 30, 2024
RP MANAGEMENT, LLC1.87%13.29%3,846,154--23,769,232Jun 30, 2024
ROCK SPRINGS CAPITAL MANAGEMENT LP1.76%0.67%3,619,258123,0023.52%22,367,014Jun 30, 2024
GW&K INVESTMENT MANAGEMENT, LLC1.65%0.19%3,404,700-49,208-1.42%21,041,000Jun 30, 2024
FISHER ASSET MANAGEMENT, LLC1.39%0.01%2,856,703-27,916-0.97%17,654,422Jun 30, 2024
VOLORIDGE INVESTMENT MANAGEMENT, LLC1.26%0.06%2,590,8611,623,139167.73%16,011,521Jun 30, 2024
GOLDMAN SACHS GROUP INC1.23%0.00%2,530,259604,89431.42%15,637,001Jun 30, 2024
BOOTHBAY FUND MANAGEMENT, LLC1.04%0.31%2,135,2631,672,929361.84%13,195,925Jun 30, 2024
RICE HALL JAMES & ASSOCIATES, LLC1.01%0.77%2,079,641-71,904-3.34%12,852,181Jun 30, 2024
CUTTER CAPITAL MANAGEMENT, LP0.96%3.68%1,975,298-130,161-6.18%12,207,342Jun 30, 2024
PRICE T ROWE ASSOCIATES INC /MD/0.95%0.00%1,948,9841,818,2091390.33%12,046,000Jun 30, 2024

BioCryst Pharmaceuticals's largest institutional shareholder is BLACKROCK INC., holding 9.68% of the company's total share outstanding, currently valued at $123.33M. The top 10 institutional shareholders own together 47.80% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
RP MANAGEMENT, LLC1.87%13.29%3,846,154--23,769,232Jun 30, 2024
CALIGAN PARTNERS LP2.23%6.64%4,598,7373,840,235506.29%28,420,195Jun 30, 2024
KYNAM CAPITAL MANAGEMENT, LP4.28%4.21%8,826,7102,299,21935.22%54,549,068Jun 30, 2024
CUTTER CAPITAL MANAGEMENT, LP0.96%3.68%1,975,298-130,161-6.18%12,207,342Jun 30, 2024
ORACLE INVESTMENT MANAGEMENT INC0.26%3.09%535,558--3,309,748Jun 30, 2024
ALPHACENTRIC ADVISORS LLC0.33%3.07%675,000--4,171,500Jun 30, 2024
SARISSA CAPITAL MANAGEMENT LP0.53%1.14%1,094,168--6,761,958Jun 30, 2024
DAFNA CAPITAL MANAGEMENT LLC0.34%1.04%704,500-5,000-0.70%4,353,810Jun 30, 2024
AVORO CAPITAL ADVISORS LLC6.10%1.03%12,570,000-480,000-3.68%77,682,600Jun 30, 2024
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)3.95%0.84%8,135,8043,140,80462.88%50,279,269Jun 30, 2024
KNOTT DAVID M JR0.15%0.77%314,307314,307100.00%1,942,000Jun 30, 2024
RICE HALL JAMES & ASSOCIATES, LLC1.01%0.77%2,079,641-71,904-3.34%12,852,181Jun 30, 2024
PROSIGHT MANAGEMENT, LP0.19%0.74%398,700-1,001,300-71.52%2,463,966Jun 30, 2024
ROCK SPRINGS CAPITAL MANAGEMENT LP1.76%0.67%3,619,258123,0023.52%22,367,014Jun 30, 2024
TANG CAPITAL MANAGEMENT LLC0.39%0.50%800,000--4,944,000Jun 30, 2024
EVERSEPT PARTNERS, LP0.56%0.49%1,152,573-279,854-19.54%7,122,901Jun 30, 2024
PARKMAN HEALTHCARE PARTNERS LLC0.19%0.33%400,448400,448100.00%2,474,769Jun 30, 2024
BOOTHBAY FUND MANAGEMENT, LLC1.04%0.31%2,135,2631,672,929361.84%13,195,925Jun 30, 2024
BIRCHVIEW CAPITAL, LP0.02%0.23%40,00020,000100.00%247,200Jun 30, 2024
PDT PARTNERS, LLC0.18%0.21%366,770-13,753-3.61%2,266,639Jun 30, 2024

The largest BioCryst Pharmaceuticals shareholder by % of total assets is RP MANAGEMENT, LLC. The company owns 3.85M shares of BioCryst Pharmaceuticals (BCRX), representing 13.29% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CALIGAN PARTNERS LP2.23%6.64%4,598,7373,840,235506.29%28,420,195Jun 30, 2024
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)3.95%0.84%8,135,8043,140,80462.88%50,279,269Jun 30, 2024
ALKEON CAPITAL MANAGEMENT LLC3.45%0.07%7,099,4843,000,00073.18%43,874,811Jun 30, 2024
KYNAM CAPITAL MANAGEMENT, LP4.28%4.21%8,826,7102,299,21935.22%54,549,068Jun 30, 2024
NUVEEN ASSET MANAGEMENT, LLC2.18%0.01%4,495,3851,875,52471.59%27,781,480Jun 30, 2024
PRICE T ROWE ASSOCIATES INC /MD/0.95%0.00%1,948,9841,818,2091390.33%12,046,000Jun 30, 2024
BOOTHBAY FUND MANAGEMENT, LLC1.04%0.31%2,135,2631,672,929361.84%13,195,925Jun 30, 2024
VOLORIDGE INVESTMENT MANAGEMENT, LLC1.26%0.06%2,590,8611,623,139167.73%16,011,521Jun 30, 2024
BLACKROCK INC.9.68%0.00%19,956,2551,515,5268.22%123,329,655Jun 30, 2024
VANGUARD GROUP INC9.11%0.00%18,769,4931,092,7266.18%115,995,467Jun 30, 2024
CUBIST SYSTEMATIC STRATEGIES, LLC0.54%0.05%1,112,232935,132528.02%6,873,591Jun 30, 2024
TREXQUANT INVESTMENT LP0.50%0.10%1,037,171920,238786.98%6,409,717Jun 30, 2024
NORGES BANK0.32%0.00%651,635651,635100.00%4,027,104Jun 30, 2024
GOLDMAN SACHS GROUP INC1.23%0.00%2,530,259604,89431.42%15,637,001Jun 30, 2024
JACOBS LEVY EQUITY MANAGEMENT, INC0.36%0.02%739,599583,480373.74%4,570,722Jun 30, 2024
JPMORGAN CHASE & CO0.36%0.00%747,531478,455177.81%4,619,742Jun 30, 2024
SCHONFELD STRATEGIC ADVISORS LLC0.22%0.02%452,603452,603100.00%2,797,085Jun 30, 2024
PARKMAN HEALTHCARE PARTNERS LLC0.19%0.33%400,448400,448100.00%2,474,769Jun 30, 2024
GSA CAPITAL PARTNERS LLP0.18%0.16%363,838363,838100.00%2,249,000Jun 30, 2024
D. E. SHAW & CO., INC.0.17%0.00%350,800316,924935.54%2,167,944Jun 30, 2024

As of Jun 30 2024, BioCryst Pharmaceuticals's largest institutional buyer is CALIGAN PARTNERS LP. The company purchased 3.84M stocks of BCRX, valued at $28.42M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BAKER BROS. ADVISORS LP0.04%0.01%75,778-10,050,398-99.25%468,308Jun 30, 2024
STATE STREET CORP4.54%0.00%9,346,799-8,130,545-46.52%57,763,218,000Jun 30, 2024
BRAIDWELL LP----3,379,577-100.00%-Jun 30, 2024
POINT72 ASSET MANAGEMENT, L.P.----1,616,244-100.00%-Jun 30, 2024
RAFFERTY ASSET MANAGEMENT, LLC0.23%0.01%465,731-1,104,051-70.33%2,878,218Jun 30, 2024
PROSIGHT MANAGEMENT, LP0.19%0.74%398,700-1,001,300-71.52%2,463,966Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.0.00%0.00%5,517-745,177-99.27%34,094Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD----667,394-100.00%-Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC0.47%0.01%960,180-630,200-39.63%5,933,912Jun 30, 2024
UBS GROUP AG0.19%0.00%391,485-605,070-60.72%2,419,377Jun 30, 2024
AVORO CAPITAL ADVISORS LLC6.10%1.03%12,570,000-480,000-3.68%77,682,600Jun 30, 2024
AMERIPRISE FINANCIAL INC0.91%0.00%1,865,623-469,568-20.11%11,529,551Jun 30, 2024
MORGAN STANLEY0.77%0.00%1,577,949-430,096-21.42%9,751,728Jun 30, 2024
ASSENAGON ASSET MANAGEMENT S.A.0.03%0.00%64,907-321,978-83.22%401,125Jun 30, 2024
DEUTSCHE BANK AG\0.21%0.00%431,994-316,800-42.31%2,669,723Jun 30, 2024
EVERSEPT PARTNERS, LP0.56%0.49%1,152,573-279,854-19.54%7,122,901Jun 30, 2024
SEGALL BRYANT & HAMILL, LLC0.74%0.17%1,526,481-222,967-12.74%9,433,653Jun 30, 2024
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC----212,781-100.00%-Jun 30, 2024
MILLENNIUM MANAGEMENT LLC----201,200-100.00%-Jun 30, 2024
EXODUSPOINT CAPITAL MANAGEMENT, LP----172,961-100.00%-Jun 30, 2024

As of Jun 30 2024, BioCryst Pharmaceuticals's biggest institutional seller is BAKER BROS. ADVISORS LP. The company sold -10.05M shares of BCRX, valued at $468.31K.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
NORGES BANK0.32%0.00%651,635651,635100.00%4,027,104Jun 30, 2024
SCHONFELD STRATEGIC ADVISORS LLC0.22%0.02%452,603452,603100.00%2,797,085Jun 30, 2024
PARKMAN HEALTHCARE PARTNERS LLC0.19%0.33%400,448400,448100.00%2,474,769Jun 30, 2024
KNOTT DAVID M JR0.15%0.77%314,307314,307100.00%1,942,000Jun 30, 2024
POINT72 EUROPE (LONDON) LLP0.13%0.14%267,649267,649100.00%1,654,069Jun 30, 2024
TD ASSET MANAGEMENT INC0.12%0.00%240,600240,600100.00%1,486,908Jun 30, 2024
CAPULA MANAGEMENT LTD0.08%0.01%161,296161,296100.00%996,809Jun 30, 2024
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD.0.06%0.00%113,527113,527100.00%700,370Jun 30, 2024
COREBRIDGE FINANCIAL, INC.0.05%0.00%111,167111,167100.00%687,012Jun 30, 2024
Y-INTERCEPT (HONG KONG) LTD0.04%0.03%89,35289,352100.00%552,195Jun 30, 2024
POINT72 ASIA (SINGAPORE) PTE. LTD.0.04%0.09%72,66672,666100.00%449,079Jun 30, 2024
PEAK6 INVESTMENTS LLC0.03%0.00%70,00070,000100.00%432,600Jun 30, 2024
DYNAMIC TECHNOLOGY LAB PRIVATE LTD0.02%0.03%40,15940,159100.00%248,000Jun 30, 2024
ADAR1 CAPITAL MANAGEMENT, LLC0.01%0.03%29,40029,400100.00%181,692Jun 30, 2024
LEISURE CAPITAL MANAGEMENT0.01%0.08%28,00028,000100.00%173,040Jun 30, 2024
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO0.01%0.00%22,75422,754100.00%140,620Jun 30, 2024
ALPINE GLOBAL MANAGEMENT, LLC0.01%0.02%20,07120,071100.00%124,039Jun 30, 2024
HEADLANDS TECHNOLOGIES LLC0.01%0.01%16,75016,750100.00%103,515Jun 30, 2024
BRIDGEFRONT CAPITAL, LLC0.01%0.03%12,91412,914100.00%79,809Jun 30, 2024
DRW SECURITIES, LLC0.01%0.00%11,98711,987100.00%74,079Jun 30, 2024
NVERSES CAPITAL, LLC0.00%0.04%10,20010,200100.00%63,036Jun 30, 2024
INCEPTIONR LLC0.00%0.02%10,13810,138100.00%62,653Jun 30, 2024
BARCLAYS PLC0.00%-10,00010,000100.00%62,000Jun 30, 2024
KBC GROUP NV0.00%0.00%8,6358,635100.00%53,000Jun 30, 2024
UBS GROUP AG0.00%-8,0008,000100.00%49,440Jun 30, 2024
ACTIVEST WEALTH MANAGEMENT0.00%0.00%2,0002,000100.00%12,360Jun 30, 2024
OLIVER LAGORE VANVALIN INVESTMENT GROUP0.00%0.00%1,1801,180100.00%7,292Jun 30, 2024
OPTIVER HOLDING B.V.0.00%-936936100.00%5,784Jun 30, 2024
BESSEMER GROUP INC0.00%-740740100.00%5,000Jun 30, 2024
BELL INVESTMENT ADVISORS, INC0.00%0.00%107107100.00%662Jun 30, 2024
ASPIRE PRIVATE CAPITAL, LLC-0.00%100100100.00%618Jun 30, 2024
PARALLEL ADVISORS, LLC--9393100.00%575Jun 30, 2024
INNEALTA CAPITAL, LLC-0.00%7070100.00%433Jun 30, 2024

BioCryst Pharmaceuticals's largest new institutional shareholder by number of shares is NORGES BANK, purchased 651.63K shares, valued at $4.03M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BRAIDWELL LP----3,379,577-100.00%-Jun 30, 2024
POINT72 ASSET MANAGEMENT, L.P.----1,616,244-100.00%-Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD----667,394-100.00%-Jun 30, 2024
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC----212,781-100.00%-Jun 30, 2024
MILLENNIUM MANAGEMENT LLC----201,200-100.00%-Jun 30, 2024
EXODUSPOINT CAPITAL MANAGEMENT, LP----172,961-100.00%-Jun 30, 2024
FIRST TRUST ADVISORS LP----141,387-100.00%-Jun 30, 2024
REDWOOD INVESTMENT MANAGEMENT, LLC----122,270-100.00%-Jun 30, 2024
SQUAREPOINT OPS LLC----97,614-100.00%-Jun 30, 2024
AMERICAN INTERNATIONAL GROUP, INC.----93,415-100.00%-Jun 30, 2024
SHERBROOKE PARK ADVISERS LLC----78,814-100.00%-Jun 30, 2024
BOOTHBAY FUND MANAGEMENT, LLC----73,700-100.00%-Jun 30, 2024
CAPTION MANAGEMENT, LLC----60,000-100.00%-Jun 30, 2024
GROUP ONE TRADING, L.P.----46,044-100.00%-Jun 30, 2024
HANDELSBANKEN FONDER AB----45,900-100.00%-Jun 30, 2024
ENTRYPOINT CAPITAL, LLC----42,679-100.00%-Jun 30, 2024
WORTH VENTURE PARTNERS, LLC----39,000-100.00%-Jun 30, 2024
NAN FUNG GROUP HOLDINGS LTD----36,847-100.00%-Jun 30, 2024
UBS OCONNOR LLC----32,630-100.00%-Jun 30, 2024
PEAK6 INVESTMENTS LLC----25,000-100.00%-Jun 30, 2024
WALLEYE CAPITAL LLC----24,800-100.00%-Jun 30, 2024
QUANTBOT TECHNOLOGIES LP----22,300-100.00%-Jun 30, 2024
BARCLAYS PLC----20,000-100.00%-Jun 30, 2024
QUARRY LP----20,000-100.00%-Jun 30, 2024
SG AMERICAS SECURITIES, LLC----13,548-100.00%-Jun 30, 2024
LAZARD ASSET MANAGEMENT LLC----13,179-100.00%-Jun 30, 2024
J.W. COLE ADVISORS, INC.----12,600-100.00%-Jun 30, 2024
TWO SIGMA SECURITIES, LLC----10,119-100.00%-Jun 30, 2024
METROPOLITAN LIFE INSURANCE CO/NY----10,087-100.00%-Jun 30, 2024
CONCOURSE FINANCIAL GROUP SECURITIES, INC.----1,300-100.00%-Jun 30, 2024
PARK PLACE CAPITAL CORP----237-100.00%-Jun 30, 2024
FUTURE FINANCIAL WEALTH MANAGMENT LLC----180-100.00%-Jun 30, 2024
PRIVATE WEALTH MANAGEMENT GROUP, LLC----157-100.00%-Jun 30, 2024
MASSMUTUAL TRUST CO FSB/ADV----70-100.00%-Jun 30, 2024
FARTHER FINANCE ADVISORS, LLC----60-100.00%-Jun 30, 2024
JFS WEALTH ADVISORS, LLC----40-100.00%-Jun 30, 2024
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC----36-100.00%-Jun 30, 2024
SJS INVESTMENT CONSULTING INC.----20-100.00%-Jun 30, 2024
DINUZZO PRIVATE WEALTH, INC.----13-100.00%-Jun 30, 2024
FINANCIAL GRAVITY ASSET MANAGEMENT, INC.----8-100.00%-Jun 30, 2024
TFO-TDC, LLC----3-100.00%-Jun 30, 2024

BioCryst Pharmaceuticals's largest sold out institutional shareholder by shares sold is BRAIDWELL LP, sold -3.38M shares, valued at -, as of undefined.

BioCryst Pharmaceuticals Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
LORD ABBETT DEVELOPING GROWTH FUND, INC.2.64%2,451,869--Jan 31, 2024
SPARROW FUNDS1.73%6,170--Feb 29, 2024
TEKLA LIFE SCIENCES INVESTORS0.43%202,491--Mar 31, 2024
Vanguard Montgomery Funds0.41%97,207--Mar 31, 2024
TEKLA HEALTHCARE INVESTORS0.35%302,037--Mar 31, 2024
Nuveen NASDAQ 100 Dynamic Overwrite Fund0.33%39,296--Mar 31, 2024
Federated Hermes MDT Series0.32%791,248--Jan 31, 2024
VANGUARD VALLEY FORGE FUNDS0.25%129,109--Mar 31, 2024
Advantage Advisers Xanthus Fund, L.L.C.0.20%585,573347,345145.80%Mar 31, 2024
REYNOLDS FUNDS INC0.16%1,800--Mar 31, 2024
Voya EQUITY TRUST0.15%221,64073,44049.55%Feb 29, 2024
ACAP Strategic Fund0.14%2,017,8761,200,338146.82%Mar 31, 2024
VICTORY VARIABLE INSURANCE FUNDS0.13%64,550--Mar 31, 2024
FIDELITY ADVISOR SERIES VII0.10%884,000--Jan 31, 2024
Humankind Benefit Corp0.08%1,67139731.16%Dec 31, 2023
VANGUARD EXPLORER FUND0.07%891,794496,554125.63%Jan 31, 2024
NORTHERN FUNDS0.06%8,000,000--Mar 28, 2024
QUANTITATIVE MASTER SERIES LLC0.05%334,640-9,201-2.68%Mar 31, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.05%28,746--Mar 31, 2024
FIDELITY CAPITAL TRUST0.04%482,600--Jan 31, 2024
FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND0.04%158,101--Jan 31, 2024
SMALLCAP WORLD FUND INC0.04%2,840,000--Mar 31, 2024
ETFis Series Trust I0.04%50,73112,41032.38%Jan 31, 2024
VANGUARD INDEX FUNDS0.03%13,683,819-3,758,409-21.55%Mar 31, 2024
ALGER FUNDS0.03%30,000--Jan 31, 2024
VICTORY PORTFOLIOS0.03%970,450--Mar 31, 2024
NEXPOINT FUNDS I0.03%115,000--Dec 31, 2023
FIDELITY SELECT PORTFOLIOS0.03%1,787,181-794,300-30.77%Feb 29, 2024
AMG FUNDS0.03%801,102210,06835.54%Mar 28, 2024
BlackRock Advantage SMID Cap Fund, Inc.0.03%4,855--Mar 28, 2024
VANGUARD HORIZON FUNDS0.03%596,266207,92253.54%Mar 31, 2024
TIAA SEPARATE ACCOUNT VA 10.02%5,428--Mar 31, 2024
JNL VARIABLE FUND LLC0.02%110,017--Mar 31, 2020
BNY Mellon Strategic Funds, Inc.0.02%42,576-25,015-37.01%Feb 29, 2024
Segall Bryant & Hamill Trust0.02%330,506--Mar 31, 2024
FORUM FUNDS0.02%39,770--Jan 31, 2024
AMERICAN CENTURY QUANTITATIVE EQUITY FUNDS, INC.0.02%38,067--Mar 31, 2024
FIDELITY COMMONWEALTH TRUST0.02%52,431--Feb 29, 2024
Nushares ETF Trust0.02%114,014--Jan 31, 2024
SCHWAB CAPITAL TRUST0.02%646,768126,13124.23%Jan 31, 2024
Fidelity Commonwealth Trust II0.01%84,44823,29038.08%Aug 31, 2023
FIDELITY SECURITIES FUND0.01%1,123,400--Jan 31, 2024
Voya VARIABLE PORTFOLIOS INC0.01%388,15255,87416.82%Mar 31, 2024
ALPS ETF Trust0.01%149,05315,19611.35%Feb 29, 2024
AMG Funds I0.01%23,194--Jan 31, 2024
CLEARWATER INVESTMENT TRUST0.01%105,5605,6235.63%Mar 28, 2024
TIAA-CREF LIFE FUNDS0.01%29,132-926-3.08%Mar 31, 2024
FIDELITY CONCORD STREET TRUST0.01%1,964,658206,06411.72%Feb 29, 2024
FORUM FUNDS II0.01%8,900--Jan 31, 2024
Destra Investment Trust0.01%14,251--Mar 31, 2024
Columbia Funds Variable Series Trust II0.01%254,126--Mar 31, 2024
Mutual of America Variable Insurance Portfolios, Inc.0.01%5,4412805.43%Sep 30, 2023
Calvert Variable Products, Inc.0.01%18,832--Mar 31, 2024
ProFunds0.01%81,16826,01447.17%Mar 31, 2024
ETF Managers Trust0.01%51,928-1,496-2.80%Dec 31, 2023
INVESCO EXCHANGE-TRADED FUND TRUST0.01%548,607--Jan 31, 2024
Direxion Shares ETF Trust0.01%917,478283,03544.61%Jan 31, 2024
FIDELITY CONTRAFUND0.01%385,988--Mar 31, 2024
SSGA FUNDS0.01%2,558--Feb 29, 2024
FIDELITY COVINGTON TRUST0.01%97,78625,83835.91%Jan 31, 2024
MUTUAL OF AMERICA INVESTMENT CORP0.01%204,414-4,185-2.01%Mar 31, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%136,382-9,913-6.78%Mar 31, 2024
VARIABLE INSURANCE PRODUCTS FUND II0.00%49,010-12,782-20.69%Mar 31, 2024
THORNBURG INVESTMENT TRUST0.00%7,000,000--Mar 31, 2024
VANGUARD QUANTITATIVE FUNDS0.00%16,700--Mar 31, 2024
GOLDMAN SACHS VARIABLE INSURANCE TRUST0.00%13,036--Mar 31, 2024
VANGUARD WORLD FUND0.00%686,3179,9361.47%Feb 29, 2024
PFM Multi-Manager Series Trust0.00%2,279--Dec 31, 2023
SunAmerica Specialty Series0.00%1,456--Apr 30, 2021
T. Rowe Price Index Trust, Inc.0.00%52,50411,39727.73%Mar 31, 2024
Meeder Funds0.00%9,834--Mar 31, 2024
Principal Exchange-Traded Funds0.00%23,519-1,934-7.60%Mar 31, 2024
VANGUARD VARIABLE INSURANCE FUNDS0.00%98,837-11,624-10.52%Mar 31, 2024
Global X Funds0.00%84,528--Jan 31, 2024
Amplify ETF Trust0.00%53,05153,051-Mar 31, 2024
SCHWAB STRATEGIC TRUST0.00%1,085,476121,27612.58%Feb 29, 2024
FundVantage Trust0.00%28,610--Mar 28, 2024
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.00%8,887-550-5.83%Mar 31, 2024
OHIO NATIONAL FUND INC0.00%27,957--Mar 31, 2024
Virtus Strategy Trust0.00%24,650--Mar 28, 2024
ARTISAN PARTNERS FUNDS INC0.00%1,770,554--Mar 31, 2024
Northern Lights Fund Trust0.00%90,000--Jan 31, 2024
Voya PARTNERS INC0.00%91,91091,910-Mar 31, 2024
OLD WESTBURY FUNDS INC0.00%139,229--Jan 31, 2024
PUTNAM ASSET ALLOCATION FUNDS0.00%34,33833,8016294.41%Mar 31, 2024
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%68,2304,2006.56%Mar 31, 2024
JANUS INVESTMENT FUND0.00%317,975--Dec 31, 2023
LORD ABBETT SERIES FUND INC0.00%53,034--Mar 31, 2024
MASTER INVESTMENT PORTFOLIO0.00%70,8028,19213.08%Mar 31, 2024
North Square Investments Trust0.00%7,210--Jan 31, 2024
VALIC Co II0.00%24,8004001.64%Feb 28, 2021
Virtus Investment Trust0.00%23,910--Mar 28, 2024
LORD ABBETT SECURITIES TRUST0.00%3,225--Jan 31, 2024
THRIVENT SERIES FUND INC0.00%76,186--Mar 28, 2024
TIAA-CREF FUNDS0.00%1,987,429712,50855.89%Jan 31, 2024
NORTHERN FUNDS0.00%80,189-1,421-1.74%Mar 28, 2024
COLLEGE RETIREMENT EQUITIES FUND0.00%564,816-1,037,650-64.75%Mar 31, 2024
Forethought Variable Insurance Trust0.00%2,143--Mar 28, 2024
LOOMIS SAYLES FUNDS II0.00%1,348,429--Mar 31, 2024
ADVISORS' INNER CIRCLE FUND0.00%11,894--Jan 31, 2024

BioCryst Pharmaceuticals's largest mutual fund holder by % of total assets is "LORD ABBETT DEVELOPING GROWTH FUND, INC.", owning 2.45M shares, compromising 2.64% of its total assets.

BioCryst Pharmaceuticals Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 24244-2.79%
31 Mar, 242511.62%
31 Dec, 232471.65%
30 Sep, 23243-2.41%
30 Jun, 23249-3.49%
31 Mar, 232584.88%
31 Dec, 222460.41%
30 Sep, 222456.06%
30 Jun, 22231-7.23%
31 Mar, 2224913.70%
31 Dec, 212190.92%
30 Sep, 212171.40%
30 Jun, 212144.39%
31 Mar, 212056.77%
31 Dec, 2019214.97%
30 Sep, 20167-6.18%
30 Jun, 2017825.35%
31 Mar, 20142-0.70%
31 Dec, 1914321.19%
30 Sep, 19118-7.09%
30 Jun, 19127-9.93%
31 Mar, 191418.46%
31 Dec, 181305.69%
30 Sep, 1812313.89%
30 Jun, 181084.85%
31 Mar, 18103-13.45%
31 Dec, 17119-10.53%
30 Sep, 171334.72%
30 Jun, 17127-3.79%
31 Mar, 17132-2.22%
31 Dec, 1613517.39%
30 Sep, 1611510.58%
30 Jun, 16104-7.14%
31 Mar, 16112-13.85%
31 Dec, 15130-3.70%
30 Sep, 151353.85%
30 Jun, 1513026.21%
31 Mar, 151035.10%
31 Dec, 1498-10.91%
30 Sep, 141100.92%
30 Jun, 1410919.78%
31 Mar, 149112.35%
31 Dec, 13812.53%
30 Sep, 137917.91%
30 Jun, 1367131.03%
31 Mar, 1329-6.45%
31 Dec, 1231-13.89%
30 Sep, 1236-
30 Jun, 123620.00%
31 Mar, 1230-
31 Dec, 113042.86%
30 Sep, 1121-27.59%
30 Jun, 11293.57%
31 Mar, 112812.00%
31 Dec, 1025-3.85%
30 Sep, 1026-16.13%
30 Jun, 1031-
31 Mar, 1031-6.06%
31 Dec, 0933-
30 Sep, 093357.14%
30 Jun, 0921162.50%
31 Mar, 098-27.27%
31 Dec, 0811-21.43%
30 Sep, 081455.56%
30 Jun, 089-40.00%
31 Mar, 0815-
31 Dec, 0715-
30 Sep, 0715-16.67%
30 Jun, 07185.88%
31 Mar, 0717-10.53%
31 Dec, 061926.67%
30 Sep, 06157.14%
30 Jun, 0614-39.13%
31 Mar, 062321.05%
31 Dec, 051990.00%
30 Sep, 051011.11%
30 Jun, 059-35.71%
31 Mar, 051475.00%
31 Dec, 048-11.11%
30 Sep, 04912.50%
30 Jun, 048-
31 Mar, 04860.00%
31 Dec, 035-16.67%
30 Sep, 03650.00%
30 Jun, 034300.00%
31 Mar, 031-
31 Dec, 021-66.67%
30 Sep, 02350.00%
30 Jun, 022-33.33%
31 Mar, 023200.00%
31 Dec, 011-
30 Sep, 011-80.00%
30 Jun, 015-28.57%
31 Mar, 01716.67%
31 Dec, 00620.00%
30 Sep, 00525.00%
30 Jun, 004-20.00%
31 Mar, 00566.67%
31 Dec, 993-25.00%
30 Sep, 99433.33%
30 Jun, 993-
31 Mar, 993-

As of 30 Jun 24, 244 institutions are holding BioCryst Pharmaceuticals's shares, representing a decrease of -2.79% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 24174,191,516-2.66%
31 Mar, 24178,960,7401.28%
31 Dec, 23176,694,3881.14%
30 Sep, 23174,701,8520.47%
30 Jun, 23173,890,9811.99%
31 Mar, 23170,501,7468.59%
31 Dec, 22157,013,4505.81%
30 Sep, 22148,389,451-2.22%
30 Jun, 22151,766,08718.89%
31 Mar, 22127,656,0578.24%
31 Dec, 21117,938,02114.32%
30 Sep, 21103,165,349-1.32%
30 Jun, 21104,545,2830.05%
31 Mar, 21104,495,557-13.26%
31 Dec, 20120,470,556-5.85%
30 Sep, 20127,958,212-3.83%
30 Jun, 20133,056,5128.64%
31 Mar, 20122,469,842-10.64%
31 Dec, 19137,059,08538.89%
30 Sep, 1998,683,356-1.46%
30 Jun, 19100,141,124-1.26%
31 Mar, 19101,420,2120.22%
31 Dec, 18101,199,4101.07%
30 Sep, 18100,130,20914.37%
30 Jun, 1887,552,789-1.62%
31 Mar, 1888,997,451-1.35%
31 Dec, 1790,215,0937.90%
30 Sep, 1783,607,14721.11%
30 Jun, 1769,035,3192.06%
31 Mar, 1767,642,49415.92%
31 Dec, 1658,351,5183.20%
30 Sep, 1656,541,5379.15%
30 Jun, 1651,802,415-6.65%
31 Mar, 1655,495,301-11.97%
31 Dec, 1563,043,439-2.95%
30 Sep, 1564,961,4333.08%
30 Jun, 1563,018,938-3.17%
31 Mar, 1565,081,1877.01%
31 Dec, 1460,815,1507.12%
30 Sep, 1456,770,2927.08%
30 Jun, 1453,017,14921.86%
31 Mar, 1443,505,80423.25%
31 Dec, 1335,298,02717.64%
30 Sep, 1330,004,80685.23%
30 Jun, 1316,198,46281.30%
31 Mar, 138,934,723-4.14%
31 Dec, 129,320,49282.15%
30 Sep, 125,116,930-25.18%
30 Jun, 126,838,61139.02%
31 Mar, 124,919,20514.85%
31 Dec, 114,283,07710.15%
30 Sep, 113,888,556-18.98%
30 Jun, 114,799,4312.19%
31 Mar, 114,696,66823.57%
31 Dec, 103,800,897-56.85%
30 Sep, 108,808,0921.70%
30 Jun, 108,661,019-0.83%
31 Mar, 108,733,4753.62%
31 Dec, 098,428,136195.68%
30 Sep, 092,850,430-66.32%
30 Jun, 098,463,350-13.59%
31 Mar, 099,793,949-10.22%
31 Dec, 0810,908,88914.31%
30 Sep, 089,542,9847.35%
30 Jun, 088,889,426-0.79%
31 Mar, 088,960,061-13.88%
31 Dec, 0710,404,136-4.45%
30 Sep, 0710,888,11373.90%
30 Jun, 076,261,060104.61%
31 Mar, 073,060,041-44.83%
31 Dec, 065,546,114-3.27%
30 Sep, 065,733,68735.01%
30 Jun, 064,246,891-17.43%
31 Mar, 065,143,23425.08%
31 Dec, 054,112,0456.97%
30 Sep, 053,843,934-13.07%
30 Jun, 054,421,87010.39%
31 Mar, 054,005,58519.33%
31 Dec, 043,356,7152.54%
30 Sep, 043,273,524108.09%
30 Jun, 041,573,142-5.62%
31 Mar, 041,666,79127.87%
31 Dec, 031,303,465-57.55%
30 Sep, 033,070,7644713.34%
30 Jun, 0363,797-97.11%
31 Mar, 032,210,4001049.45%
31 Dec, 02192,300-34.24%
30 Sep, 02292,4211015.09%
30 Jun, 0226,224-54.75%
31 Mar, 0257,950-3.07%
31 Dec, 0159,786-3.04%
30 Sep, 0161,662-70.00%
30 Jun, 01205,542-88.24%
31 Mar, 011,747,350-1.21%
31 Dec, 001,768,775460.27%
30 Sep, 00315,703-69.81%
30 Jun, 001,045,82260.23%
31 Mar, 00652,711152.95%
31 Dec, 99258,039-12.96%
30 Sep, 99296,47543.50%
30 Jun, 99206,598-19.12%
31 Mar, 99255,429-

BioCryst Pharmaceuticals (BCRX) has 174.19M shares outstanding as of 30 Jun 24, down -2.66% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 2484.53%1.12%
31 Mar, 2486.85%1.03%
31 Dec, 2391.93%1.08%
30 Sep, 2392.12%1.09%
30 Jun, 2391.95%1.12%
31 Mar, 2390.45%1.28%
31 Dec, 2284.00%1.32%
30 Sep, 2279.70%1.17%
30 Jun, 2282.51%1.73%
31 Mar, 2269.04%1.64%
31 Dec, 2164.86%1.95%
30 Sep, 2157.60%1.67%
30 Jun, 2158.69%1.69%
31 Mar, 2158.92%1.27%
31 Dec, 2068.21%1.30%
30 Sep, 2072.49%1.07%
30 Jun, 2082.35%1.30%
31 Mar, 2079.45%0.57%
31 Dec, 19118.56%1.48%
30 Sep, 1989.37%1.08%
30 Jun, 1990.76%1.07%
31 Mar, 1992.06%1.08%
31 Dec, 1892.17%1.02%
30 Sep, 1894.99%1.21%
30 Jun, 1888.63%1.09%
31 Mar, 1890.27%0.79%
31 Dec, 17106.83%1.07%
30 Sep, 17100.04%1.36%
30 Jun, 1785.85%1.06%
31 Mar, 1789.99%1.44%
31 Dec, 1679.18%1.35%
30 Sep, 1676.68%1.55%
30 Jun, 1670.29%1.24%
31 Mar, 1675.40%1.01%
31 Dec, 1586.48%1.10%
30 Sep, 1588.67%1.18%
30 Jun, 1586.75%1.07%
31 Mar, 1589.96%1.08%
31 Dec, 1491.08%1.46%
30 Sep, 1479.07%1.14%
30 Jun, 1483.30%1.56%
31 Mar, 1473.01%2.05%
31 Dec, 1359.73%2.17%
30 Sep, 1352.53%5.72%
30 Jun, 1330.30%9.90%
31 Mar, 1317.49%5.21%
31 Dec, 1218.32%17.96%
30 Sep, 1210.10%5.23%
30 Jun, 1213.89%12.74%
31 Mar, 1210.44%11.66%
31 Dec, 119.46%12.77%
30 Sep, 118.61%7.60%
30 Jun, 1110.64%9.76%
31 Mar, 1110.44%14.58%
31 Dec, 108.46%2.20%
30 Sep, 1019.62%5.18%
30 Jun, 1019.46%4.92%
31 Mar, 1019.88%4.24%
31 Dec, 0921.65%39.42%
30 Sep, 097.41%1.51%
30 Jun, 0922.14%3.37%
31 Mar, 0925.64%3.12%
31 Dec, 0828.66%4.57%
30 Sep, 0825.05%4.61%
30 Jun, 0823.32%4.21%
31 Mar, 0823.54%3.14%
31 Dec, 0727.37%2.71%
30 Sep, 0731.77%7.01%
30 Jun, 0721.28%19.48%
31 Mar, 0710.45%2.89%
31 Dec, 0619.03%4.94%
30 Sep, 0619.62%9.27%
30 Jun, 0614.55%4.61%
31 Mar, 0617.77%6.95%
31 Dec, 0515.99%7.43%
30 Sep, 0514.67%5.13%
30 Jun, 0516.91%5.88%
31 Mar, 0516.96%6.74%
31 Dec, 0415.86%6.97%
30 Sep, 0415.08%28.48%
30 Jun, 047.28%10.05%
31 Mar, 048.51%15.70%
31 Dec, 037.36%2.44%
30 Sep, 0317.36%13315.31%
30 Jun, 030.36%0.23%
31 Mar, 0312.51%1053.35%
31 Dec, 021.09%39.71%
30 Sep, 021.66%7492.94%
30 Jun, 020.15%137.56%
31 Mar, 020.33%284.76%
31 Dec, 010.34%275.65%
30 Sep, 010.35%25.57%
30 Jun, 011.17%1.18%
31 Mar, 019.96%9.79%
31 Dec, 0010.09%310.72%
30 Sep, 001.80%5.02%
30 Jun, 005.99%42.27%
31 Mar, 003.76%133.71%
31 Dec, 991.68%43.63%
30 Sep, 991.96%103.19%
30 Jun, 991.38%47.54%
31 Mar, 991.70%-

As of 30 Jun 24, BioCryst Pharmaceuticals is held by 84.53% institutional shareholders, representing a 1.12% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 241246.90%
31 Mar, 241163.57%
31 Dec, 23112-7.44%
30 Sep, 23121-1.63%
30 Jun, 23123-6.82%
31 Mar, 23132-2.22%
31 Dec, 2213522.73%
30 Sep, 22110-
30 Jun, 221100.92%
31 Mar, 22109-3.54%
31 Dec, 2111313.00%
30 Sep, 21100-3.85%
30 Jun, 21104-
31 Mar, 211046.12%
31 Dec, 20988.89%
30 Sep, 2090-15.09%
30 Jun, 2010637.66%
31 Mar, 2077-20.62%
31 Dec, 199794.00%
30 Sep, 1950-13.79%
30 Jun, 1958-20.55%
31 Mar, 197335.19%
31 Dec, 1854-12.90%
30 Sep, 186263.16%
30 Jun, 1838-9.52%
31 Mar, 1842-33.33%
31 Dec, 1763-
30 Sep, 176314.55%
30 Jun, 1755-19.12%
31 Mar, 17689.68%
31 Dec, 166231.91%
30 Sep, 16476.82%
30 Jun, 1644-24.14%
31 Mar, 165816.00%
31 Dec, 1550-25.37%
30 Sep, 1567-15.19%
30 Jun, 157941.07%
31 Mar, 155612.00%
31 Dec, 1450-15.25%
30 Sep, 1459-13.24%
30 Jun, 146833.33%
31 Mar, 14518.51%
31 Dec, 13474.44%
30 Sep, 1345-2.17%
30 Jun, 1346228.57%
31 Mar, 1314-6.67%
31 Dec, 1215-31.82%
30 Sep, 1222-15.38%
30 Jun, 122644.44%
31 Mar, 1218-14.29%
31 Dec, 112175.00%
30 Sep, 11129.09%
30 Jun, 1111-35.29%
31 Mar, 111730.77%
31 Dec, 101362.50%
30 Sep, 108-60.00%
30 Jun, 1020-4.76%
31 Mar, 1021-8.70%
31 Dec, 092315.00%
30 Sep, 092025.00%
30 Jun, 0916700.00%
31 Mar, 092-60.00%
31 Dec, 085-16.67%
30 Sep, 086200.00%
30 Jun, 082-66.67%
31 Mar, 086-
31 Dec, 076-
30 Sep, 076-14.29%
30 Jun, 077-30.00%
31 Mar, 071025.00%
31 Dec, 068-
30 Sep, 068100.00%
30 Jun, 064-69.23%
31 Mar, 06138.33%
31 Dec, 0512100.00%
30 Sep, 05620.00%
30 Jun, 055-54.55%
31 Mar, 0511266.67%
31 Dec, 043-57.14%
30 Sep, 04716.67%
30 Jun, 04620.00%
31 Mar, 04525.00%
31 Dec, 034-
30 Sep, 034-
30 Jun, 034300.00%
31 Mar, 031-
31 Dec, 02--100.00%
30 Sep, 023-
30 Jun, 02--100.00%
31 Mar, 022-
31 Dec, 01--
30 Sep, 01--100.00%
30 Jun, 011-75.00%
31 Mar, 014-
31 Dec, 004-20.00%
30 Sep, 00566.67%
30 Jun, 003-40.00%
31 Mar, 005150.00%
31 Dec, 992-
30 Sep, 992100.00%
30 Jun, 991-66.67%
31 Mar, 993-

124 institutional shareholders have increased their position in BCRX stock as of 30 Jun 24 compared to 116 in the previous quarter (a 6.90% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 2467-4.29%
31 Mar, 2470-10.26%
31 Dec, 237834.48%
30 Sep, 2358-1.69%
30 Jun, 2359-18.06%
31 Mar, 237230.91%
31 Dec, 2255-14.06%
30 Sep, 226410.34%
30 Jun, 2258-23.68%
31 Mar, 227649.02%
31 Dec, 2151-22.73%
30 Sep, 216615.79%
30 Jun, 2157-20.83%
31 Mar, 217230.91%
31 Dec, 205534.15%
30 Sep, 20412.50%
30 Jun, 20408.11%
31 Mar, 203768.18%
31 Dec, 1922-42.11%
30 Sep, 193822.58%
30 Jun, 193119.23%
31 Mar, 1926-35.00%
31 Dec, 184053.85%
30 Sep, 1826-25.71%
30 Jun, 18356.06%
31 Mar, 183337.50%
31 Dec, 1724-17.24%
30 Sep, 1729-17.14%
30 Jun, 17359.38%
31 Mar, 17326.67%
31 Dec, 163015.38%
30 Sep, 1626-10.34%
30 Jun, 16297.41%
31 Mar, 1627-28.95%
31 Dec, 1538-9.52%
30 Sep, 154268.00%
30 Jun, 1525-
31 Mar, 15254.17%
31 Dec, 1424-4.00%
30 Sep, 142556.25%
30 Jun, 1416-20.00%
31 Mar, 142025.00%
31 Dec, 1316-11.11%
30 Sep, 1318157.14%
30 Jun, 137-12.50%
31 Mar, 138-20.00%
31 Dec, 121011.11%
30 Sep, 129125.00%
30 Jun, 124-50.00%
31 Mar, 128100.00%
31 Dec, 11433.33%
30 Sep, 113-66.67%
30 Jun, 119350.00%
31 Mar, 112-50.00%
31 Dec, 104-50.00%
30 Sep, 108100.00%
30 Jun, 10433.33%
31 Mar, 103-40.00%
31 Dec, 095-37.50%
30 Sep, 098100.00%
30 Jun, 094100.00%
31 Mar, 092-33.33%
31 Dec, 083-
30 Sep, 08350.00%
30 Jun, 082-
31 Mar, 082-
31 Dec, 072-60.00%
30 Sep, 07525.00%
30 Jun, 07433.33%
31 Mar, 073-57.14%
31 Dec, 067250.00%
30 Sep, 062-50.00%
30 Jun, 064-20.00%
31 Mar, 065150.00%
31 Dec, 052-
30 Sep, 052-33.33%
30 Jun, 05350.00%
31 Mar, 052-
31 Dec, 042-
30 Sep, 04--
30 Jun, 04--100.00%
31 Mar, 041-
31 Dec, 03--100.00%
30 Sep, 031-
30 Jun, 03--
31 Mar, 03--100.00%
31 Dec, 021-
30 Sep, 02--100.00%
30 Jun, 021-
31 Mar, 021-
31 Dec, 011-
30 Sep, 011-66.67%
30 Jun, 013-
31 Mar, 01350.00%
31 Dec, 002-
30 Sep, 00--
30 Jun, 00--
31 Mar, 00--
31 Dec, 99--100.00%
30 Sep, 992100.00%
30 Jun, 991-
31 Mar, 99--

67 institutional shareholders have reduced their position in BCRX stock as of 30 Jun 24 compared to 70 in the previous quarter (a -4.29% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 24244-2.79%174,191,516-2.66%84.53%1.12%1246.90%67-4.29%
31 Mar, 242511.62%178,960,7401.28%86.85%1.03%1163.57%70-10.26%
31 Dec, 232471.65%176,694,3881.14%91.93%1.08%112-7.44%7834.48%
30 Sep, 23243-2.41%174,701,8520.47%92.12%1.09%121-1.63%58-1.69%
30 Jun, 23249-3.49%173,890,9811.99%91.95%1.12%123-6.82%59-18.06%
31 Mar, 232584.88%170,501,7468.59%90.45%1.28%132-2.22%7230.91%
31 Dec, 222460.41%157,013,4505.81%84.00%1.32%13522.73%55-14.06%
30 Sep, 222456.06%148,389,451-2.22%79.70%1.17%110-6410.34%
30 Jun, 22231-7.23%151,766,08718.89%82.51%1.73%1100.92%58-23.68%
31 Mar, 2224913.70%127,656,0578.24%69.04%1.64%109-3.54%7649.02%
31 Dec, 212190.92%117,938,02114.32%64.86%1.95%11313.00%51-22.73%
30 Sep, 212171.40%103,165,349-1.32%57.60%1.67%100-3.85%6615.79%
30 Jun, 212144.39%104,545,2830.05%58.69%1.69%104-57-20.83%
31 Mar, 212056.77%104,495,557-13.26%58.92%1.27%1046.12%7230.91%
31 Dec, 2019214.97%120,470,556-5.85%68.21%1.30%988.89%5534.15%
30 Sep, 20167-6.18%127,958,212-3.83%72.49%1.07%90-15.09%412.50%
30 Jun, 2017825.35%133,056,5128.64%82.35%1.30%10637.66%408.11%
31 Mar, 20142-0.70%122,469,842-10.64%79.45%0.57%77-20.62%3768.18%
31 Dec, 1914321.19%137,059,08538.89%118.56%1.48%9794.00%22-42.11%
30 Sep, 19118-7.09%98,683,356-1.46%89.37%1.08%50-13.79%3822.58%
30 Jun, 19127-9.93%100,141,124-1.26%90.76%1.07%58-20.55%3119.23%
31 Mar, 191418.46%101,420,2120.22%92.06%1.08%7335.19%26-35.00%
31 Dec, 181305.69%101,199,4101.07%92.17%1.02%54-12.90%4053.85%
30 Sep, 1812313.89%100,130,20914.37%94.99%1.21%6263.16%26-25.71%
30 Jun, 181084.85%87,552,789-1.62%88.63%1.09%38-9.52%356.06%
31 Mar, 18103-13.45%88,997,451-1.35%90.27%0.79%42-33.33%3337.50%
31 Dec, 17119-10.53%90,215,0937.90%106.83%1.07%63-24-17.24%
30 Sep, 171334.72%83,607,14721.11%100.04%1.36%6314.55%29-17.14%
30 Jun, 17127-3.79%69,035,3192.06%85.85%1.06%55-19.12%359.38%
31 Mar, 17132-2.22%67,642,49415.92%89.99%1.44%689.68%326.67%
31 Dec, 1613517.39%58,351,5183.20%79.18%1.35%6231.91%3015.38%
30 Sep, 1611510.58%56,541,5379.15%76.68%1.55%476.82%26-10.34%
30 Jun, 16104-7.14%51,802,415-6.65%70.29%1.24%44-24.14%297.41%
31 Mar, 16112-13.85%55,495,301-11.97%75.40%1.01%5816.00%27-28.95%
31 Dec, 15130-3.70%63,043,439-2.95%86.48%1.10%50-25.37%38-9.52%
30 Sep, 151353.85%64,961,4333.08%88.67%1.18%67-15.19%4268.00%
30 Jun, 1513026.21%63,018,938-3.17%86.75%1.07%7941.07%25-
31 Mar, 151035.10%65,081,1877.01%89.96%1.08%5612.00%254.17%
31 Dec, 1498-10.91%60,815,1507.12%91.08%1.46%50-15.25%24-4.00%
30 Sep, 141100.92%56,770,2927.08%79.07%1.14%59-13.24%2556.25%
30 Jun, 1410919.78%53,017,14921.86%83.30%1.56%6833.33%16-20.00%
31 Mar, 149112.35%43,505,80423.25%73.01%2.05%518.51%2025.00%
31 Dec, 13812.53%35,298,02717.64%59.73%2.17%474.44%16-11.11%
30 Sep, 137917.91%30,004,80685.23%52.53%5.72%45-2.17%18157.14%
30 Jun, 1367131.03%16,198,46281.30%30.30%9.90%46228.57%7-12.50%
31 Mar, 1329-6.45%8,934,723-4.14%17.49%5.21%14-6.67%8-20.00%
31 Dec, 1231-13.89%9,320,49282.15%18.32%17.96%15-31.82%1011.11%
30 Sep, 1236-5,116,930-25.18%10.10%5.23%22-15.38%9125.00%
30 Jun, 123620.00%6,838,61139.02%13.89%12.74%2644.44%4-50.00%
31 Mar, 1230-4,919,20514.85%10.44%11.66%18-14.29%8100.00%
31 Dec, 113042.86%4,283,07710.15%9.46%12.77%2175.00%433.33%
30 Sep, 1121-27.59%3,888,556-18.98%8.61%7.60%129.09%3-66.67%
30 Jun, 11293.57%4,799,4312.19%10.64%9.76%11-35.29%9350.00%
31 Mar, 112812.00%4,696,66823.57%10.44%14.58%1730.77%2-50.00%
31 Dec, 1025-3.85%3,800,897-56.85%8.46%2.20%1362.50%4-50.00%
30 Sep, 1026-16.13%8,808,0921.70%19.62%5.18%8-60.00%8100.00%
30 Jun, 1031-8,661,019-0.83%19.46%4.92%20-4.76%433.33%
31 Mar, 1031-6.06%8,733,4753.62%19.88%4.24%21-8.70%3-40.00%
31 Dec, 0933-8,428,136195.68%21.65%39.42%2315.00%5-37.50%
30 Sep, 093357.14%2,850,430-66.32%7.41%1.51%2025.00%8100.00%
30 Jun, 0921162.50%8,463,350-13.59%22.14%3.37%16700.00%4100.00%
31 Mar, 098-27.27%9,793,949-10.22%25.64%3.12%2-60.00%2-33.33%
31 Dec, 0811-21.43%10,908,88914.31%28.66%4.57%5-16.67%3-
30 Sep, 081455.56%9,542,9847.35%25.05%4.61%6200.00%350.00%
30 Jun, 089-40.00%8,889,426-0.79%23.32%4.21%2-66.67%2-
31 Mar, 0815-8,960,061-13.88%23.54%3.14%6-2-
31 Dec, 0715-10,404,136-4.45%27.37%2.71%6-2-60.00%
30 Sep, 0715-16.67%10,888,11373.90%31.77%7.01%6-14.29%525.00%
30 Jun, 07185.88%6,261,060104.61%21.28%19.48%7-30.00%433.33%
31 Mar, 0717-10.53%3,060,041-44.83%10.45%2.89%1025.00%3-57.14%
31 Dec, 061926.67%5,546,114-3.27%19.03%4.94%8-7250.00%
30 Sep, 06157.14%5,733,68735.01%19.62%9.27%8100.00%2-50.00%
30 Jun, 0614-39.13%4,246,891-17.43%14.55%4.61%4-69.23%4-20.00%
31 Mar, 062321.05%5,143,23425.08%17.77%6.95%138.33%5150.00%
31 Dec, 051990.00%4,112,0456.97%15.99%7.43%12100.00%2-
30 Sep, 051011.11%3,843,934-13.07%14.67%5.13%620.00%2-33.33%
30 Jun, 059-35.71%4,421,87010.39%16.91%5.88%5-54.55%350.00%
31 Mar, 051475.00%4,005,58519.33%16.96%6.74%11266.67%2-
31 Dec, 048-11.11%3,356,7152.54%15.86%6.97%3-57.14%2-
30 Sep, 04912.50%3,273,524108.09%15.08%28.48%716.67%--
30 Jun, 048-1,573,142-5.62%7.28%10.05%620.00%--100.00%
31 Mar, 04860.00%1,666,79127.87%8.51%15.70%525.00%1-
31 Dec, 035-16.67%1,303,465-57.55%7.36%2.44%4---100.00%
30 Sep, 03650.00%3,070,7644713.34%17.36%13315.31%4-1-
30 Jun, 034300.00%63,797-97.11%0.36%0.23%4300.00%--
31 Mar, 031-2,210,4001049.45%12.51%1053.35%1---100.00%
31 Dec, 021-66.67%192,300-34.24%1.09%39.71%--100.00%1-
30 Sep, 02350.00%292,4211015.09%1.66%7492.94%3---100.00%
30 Jun, 022-33.33%26,224-54.75%0.15%137.56%--100.00%1-
31 Mar, 023200.00%57,950-3.07%0.33%284.76%2-1-
31 Dec, 011-59,786-3.04%0.34%275.65%--1-
30 Sep, 011-80.00%61,662-70.00%0.35%25.57%--100.00%1-66.67%
30 Jun, 015-28.57%205,542-88.24%1.17%1.18%1-75.00%3-
31 Mar, 01716.67%1,747,350-1.21%9.96%9.79%4-350.00%
31 Dec, 00620.00%1,768,775460.27%10.09%310.72%4-20.00%2-
30 Sep, 00525.00%315,703-69.81%1.80%5.02%566.67%--
30 Jun, 004-20.00%1,045,82260.23%5.99%42.27%3-40.00%--
31 Mar, 00566.67%652,711152.95%3.76%133.71%5150.00%--
31 Dec, 993-25.00%258,039-12.96%1.68%43.63%2---100.00%
30 Sep, 99433.33%296,47543.50%1.96%103.19%2100.00%2100.00%
30 Jun, 993-206,598-19.12%1.38%47.54%1-66.67%1-
31 Mar, 993-255,429-1.70%-3---

BioCryst Pharmaceuticals Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jun 25, 2024McKee Amy Edirector-S-SaleSell8,600$6.32$54.35K27,831
Jun 17, 2024SANDERS MACHELLEdirector-S-SaleSell4,689$6.00$28.13K27,742
Jun 14, 2024HEGGIE THERESAdirector-S-SaleSell6,698$6.11$40.92K52,852

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jun 25, 2024McKee Amy Edirector-S-SaleSell8,600$6.32$54.35K27,831
Jun 17, 2024SANDERS MACHELLEdirector-S-SaleSell4,689$6.00$28.13K27,742
Jun 14, 2024HEGGIE THERESAdirector-S-SaleSell6,698$6.11$40.92K52,852

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jun 25, 2024McKee Amy Edirector-S-SaleSell8,600$6.32$54.35K27,831
Jun 17, 2024SANDERS MACHELLEdirector-S-SaleSell4,689$6.00$28.13K27,742
Jun 14, 2024SANDERS MACHELLEdirector-A-AwardBuy49,933$6.30$314.58K49,933
Jun 14, 2024SANDERS MACHELLEdirector-A-AwardBuy6,820--32,431
Jun 14, 2024MILANO VINCENTdirector-A-AwardBuy6,820--74,687
Jun 14, 2024MILANO VINCENTdirector-A-AwardBuy49,933$6.30$314.58K49,933
Jun 14, 2024McKee Amy Edirector-A-AwardBuy49,933$6.30$314.58K49,933
Jun 14, 2024McKee Amy Edirector-A-AwardBuy6,820--36,431
Jun 14, 2024LEVIN ALAN Gdirector-A-AwardBuy6,820--51,771
Jun 14, 2024LEVIN ALAN Gdirector-A-AwardBuy49,933$6.30$314.58K49,933
Jun 14, 2024Hutson Nancy Jdirector-A-AwardBuy6,820--93,638
Jun 14, 2024Hutson Nancy Jdirector-A-AwardBuy49,933$6.30$314.58K49,933
Jun 14, 2024HEGGIE THERESAdirector-A-AwardBuy6,820--59,550
Jun 14, 2024HEGGIE THERESAdirector-S-SaleSell6,698$6.11$40.92K52,852
Jun 14, 2024HEGGIE THERESAdirector-A-AwardBuy49,933$6.30$314.58K49,933
Jun 14, 2024Galson Steven Kdirector-A-AwardBuy49,933$6.30$314.58K49,933
Jun 14, 2024Galson Steven Kdirector-A-AwardBuy6,820--36,431
Jun 14, 2024ASELAGE STEVEdirector-A-AwardBuy6,820--70,159
Jun 14, 2024ASELAGE STEVEdirector-A-AwardBuy49,933$6.30$314.58K49,933
Jun 14, 2024ABERCROMBIE GEORGE Bdirector-A-AwardBuy49,933$6.30$314.58K49,933

The last insider sell of BioCryst Pharmaceuticals's stock was made by McKee Amy E on Jun 25 2024, selling 8,600 shares at $6.32 per share (valued at $54.35K).

BioCryst Pharmaceuticals Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 20243031000.00%
Q1 202432150.00%
Q4 20231210120.00%
Q3 20232--
Q2 2023234575.00%
Q1 202374175.00%
Q4 20222214157.14%
Q3 20224--
Q2 2022284700.00%
Q1 202291181.82%
Q4 2021319344.44%
Q3 20211413107.69%
Q2 20212419126.32%
Q1 202195180.00%
Q4 2020218262.50%
Q3 20205--
Q2 202014--
Q1 2020172850.00%
Q4 20192121050.00%
Q3 20196--

30 total buy trades, and 3 total sell trades (buy/sell ratio of 10.00%) were made by BioCryst Pharmaceuticals's insiders, as of Q2 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024103333.33%
Q1 2024---
Q4 2023---
Q3 2023---
Q2 2023-3-
Q1 2023-1-
Q4 2022-9-
Q3 2022---
Q2 2022-2-
Q1 2022-6-
Q4 20212366.67%
Q3 2021-4-
Q2 2021-6-
Q1 2021-1-
Q4 2020-3-
Q3 20201--
Q2 2020---
Q1 2020---
Q4 20199--
Q3 2019---

As of Q2 2024, Insider owners conducted 10 open market buy trades and 3 open market sell trades of BioCryst Pharmaceuticals's stocks.

BioCryst Pharmaceuticals Peer Ownership


TickerCompany
XFORX4 Pharmaceuticals, Inc.
TGTXTG Therapeutics, Inc.
AVXLAnavex Life Sciences Corp.
ATRAAtara Biotherapeutics, Inc.
APLSApellis Pharmaceuticals, Inc.
BPMCBlueprint Medicines Corporation
DAWNDay One Biopharmaceuticals, Inc.
PDSBPDS Biotechnology Corporation
MCRBSeres Therapeutics, Inc.
VKTXViking Therapeutics, Inc.
AXSMAxsome Therapeutics, Inc.
BIVIBioVie Inc.
SAVACassava Sciences, Inc.
PIRSPieris Pharmaceuticals, Inc.
CGTXCognition Therapeutics, Inc.
IMUXImmunic, Inc.
KZRKezar Life Sciences, Inc.
KRTXKaruna Therapeutics, Inc.
INMBINmune Bio, Inc.
MDGLMadrigal Pharmaceuticals, Inc.

BCRX Ownership FAQ


BioCryst Pharmaceuticals is owned by institutional shareholders (84.53%), insiders (1.15%), and public (14.32%). The largest institutional shareholder of BioCryst Pharmaceuticals is BLACKROCK INC. (9.68% of total shares) and the top mutual fund owner is LORD ABBETT DEVELOPING GROWTH FUND, INC. (2.64% of total shares).

BioCryst Pharmaceuticals's major institutional shareholders are BLACKROCK INC., VANGUARD GROUP INC, AVORO CAPITAL ADVISORS LLC, STATE STREET CORP, and KYNAM CAPITAL MANAGEMENT, LP. The top five shareholders own together 33.71% of the company's share outstanding.

As of Jun 2024, there are 244 institutional shareholders of BioCryst Pharmaceuticals.

BLACKROCK INC owns 19.96M shares of BioCryst Pharmaceuticals, representing 9.68% of the company's total shares outstanding, valued at $123.33M (as of Jun 2024).

As of Jun 2024, VANGUARD GROUP INC holds 18.77M shares of BioCryst Pharmaceuticals (BCRX), compromising 9.11% of the company, valued at $116M.

AVORO CAPITAL ADVISORS LLC is the third largest holder of BioCryst Pharmaceuticals. The company owns 12.57M of the company's shares outstanding (worth $77.68M).